Aim immunotech to present at the medinvest biotech & pharma investor conference

Ocala, fla., march 28, 2024 (globe newswire) -- aim immunotech inc. (nyse american: aim) (“aim” or the “company”) today announced that thomas k.
AIM Ratings Summary
AIM Quant Ranking